Chrome Extension
WeChat Mini Program
Use on ChatGLM

Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion

EXPERIMENTAL HEMATOLOGY & ONCOLOGY(2024)

Cited 0|Views14
Key words
Cyclin-dependent kinase (CDK) inhibitors,Palbociclib,BCL2,Venetoclax,RB1,Mantle cell lymphoma (MCL)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined